American Heart Journal
Volume 157, Issue 3 , Pages 428-435.e2 , March 2009

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics

  • Cheryl Bushnell, MD, MHS

      Affiliations

    • Wake Forest University Health Sciences, Winston-Salem, NC
    • Corresponding Author InformationReprint requests: Cheryl Bushnell, MD, MHS, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, NC 27157.
    • ,
  • Louise Zimmer, MA, MPH

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Lee Schwamm, MD

      Affiliations

    • Massachusetts General Hospital, Boston, MA
    • ,
  • Larry B. Goldstein, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Nancy Clapp-Channing, MPH

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Tina Harding, RN, BSN

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Laura Drew, RN, BSN

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Xin Zhao, MS

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Eric Peterson, MD, MPH

      Affiliations

    • Duke University Medical Center, Durham, NC

Received 25 August 2008 ,Accepted 2 November 2008.

References 

  1. Rosamund W, Flegal K, Furie K, et al. Heart Disease and Stroke Statistics 2008 Update: a report from the American Heart Association Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
  2. Coull A, Lovett J, Rothwell P. Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326–328
  3. Petty G, Brown RJ, Sicks J. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998;50:208–216
  4. Samsa G, Bian J, Lipscomb J, et al. Epidemiology of recurrent cerebral infarction. A Medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30:338–349
  5. Alberts M, Ovbiagele B. Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol. 2007;254:1414–1426
  6. Moroney JT, Bagiella E, Paik MC, et al. Risk factors for early recurrence after ischemic stroke. The role of stroke syndrome and subtype. Stroke. 1998;29:2118–2124
  7. Hart RG, Halperin JL, Pearce LA, et al. Lessons from the Stroke Prevention in Atrial Fibrillation Trials. Ann Intern Med. 2003;138:831–838
  8. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 2004;292:1867–1874
  9. Donnan G, Fisher M, Macleod M, et al. Stroke. Lancet. 2008;371:1612–1623
  10. Hankey J, Warlow C. Treatment and secondary prevention of stroke: Evidence, costs and effects on individuals and populations. Lancet. 1999;354:1457–1463
  11. O'Rourke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention. CMAJ. 2004;170:1123–1133
  12. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35:731–735
  13. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35:2879–2883
  14. LaBresh K, Reeves M, Frankel M, et al. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the “Get With the Guidelines” program. Arch Intern Med. 2008;168:411–417
  15. Hillen T, Dundas R, Lawrence E, et al. Antithrombotic and antihypertensive management 3 months after ischemic stroke. A prospective study in an inner city population. Stroke. 2000;31:469–475
  16. Mouradian MS, Majumdar SR, Senthilselvan A, et al. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack?. Stroke. 2002;33:1656–1659
  17. Rahiman A, Saver J, Porter V, et al. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis. 2008;17:5–8
  18. Morisky D, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74
  19. Shalansky S, Levy A, Ignaszewski A. Self-reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications. Ann Pharmacother. 2004;38:1363–1368
  20. Safran D, Kosinski M, Tarlov A, et al. The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care. 1998;36:728–739
  21. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200–215
  22. The EuroQol Group . EuroQol⁎—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208
  23. Spitzer R, Kroenke K, Williams J. Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999;282:1737–1744
  24. Williams L, Brizendine E, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke. 2005;36:635–638
  25. Kroenke K, Spitzer R. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:1–7
  26. World Health Organization: Adherence to long-term therapies. Evidence for action. 2003. Available at: http://www.emro.who.int/ncd/Publications/adherence_report.pdf. Last accessed July 10, 2008.
  27. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am Heart J. 2006;19:1190–1196
  28. Ryan A. Medication compliance and older people: a review of the literature. Int J Nurs Stud. 1999;36:153–161
  29. Munger M, Van Tassell B, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. Med Gen Med. 2007;9:58
  30. Jackevicius C, Li P, Tu J. Prevalence, predictors and outcomes of primary nonadherence after acute MI. Circulation. 2008;117:1028–1036
  31. Pit S, Byles J, Cockburn J. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging. 2008;25:71–80
  32. Kapral M, Laupacis A, Phillips S, et al. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke. 2004;35:1756–1762
  33. Bhatt D, Steg P, Ohman E, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–189
  34. Tu J, Willison D, Silver F, et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med. 2004;350:1414–1421

 Dr. Mauricio G. Cohen served as guest editor for this manuscript.

PII: S0002-8703(08)00976-9

doi: 10.1016/j.ahj.2008.11.002

American Heart Journal
Volume 157, Issue 3 , Pages 428-435.e2 , March 2009

Article Tools

* Image Usage & Resolution